Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company  | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| KING PHARMACEUTICALS | Pfizer | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| Johnson and Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | WV-AG | $4,475,000 |
| Johnson & Johnson, Inc. | Johnson & Johnson | pharmaceuticals | insurance violation | 2020 | NC-INS | $150,000 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| Johnson & Johnson Vision Care Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $55,000,000 |
| Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
| Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
| JOHNSON & JOHNSON CONSUMER, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $7,853 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $2,400,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Controlled Substances Act violation | 2008 | USAO | $511,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $120,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | CA-MULTI | $506,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
| Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
| Janssen Pharmaceutical (SB) | Johnson & Johnson | pharmaceuticals | environmental violation | 2010 | EPA | $105,000 |
| Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
| Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
| IVAX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $15,120 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $5,641 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $16,215 |
| InterMune Inc. | Roche | pharmaceuticals | Family and Medical Leave Act | 2014 | WHD | $59,085 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
| Inspire Pharmaceuticals | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $15,000,000 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $20,000,000 |
| IMPAX LABORATORIES, INC | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $18,000 |
| IMO SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2014 | EPA | $77,643 |
| IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $10,001 |
| Immunex Corporation | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Immunex Corp. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
| IDEXX Reference Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | environmental violation | 2009 | AZ-DEQ | $80,000 |
| IDEXX Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | employment discrimination | 2020 | OFCCP | $200,000 |
| IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $9,600 |
| IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $32,245 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | fraud | 2001 | USAO | $5,600,000 |
| ICN Pharmaceuticals, Inc | Bausch Health | pharmaceuticals | economic sanction violation | 2004 | OFAC | $5,500 |
| HOSPIRA, INC. | Pfizer | pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $132,300 |
| HOSPIRA | Pfizer | pharmaceuticals | workplace safety or health violation | 2006 | OSHA | $6,750 |
| Hoffmann-La Roche, Inc. | Roche | pharmaceuticals | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
| Hoffmann-La Roche Inc. | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $11,000,000 |
| Hoffmann-La Roche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $130,000,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Hoechst Marion Roussel, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
| Hoechst Marion Roussel | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
| HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
| HI TECH PHARMACAL CO., INC. | Akorn Inc. | pharmaceuticals | environmental violation | 2001 | EPA | $20,500 |
| GNC HOLDINGS LLC | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,720 |
| GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
| GNC HOLDINGS INC. | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $17,858 |
| GNC | Harbin Pharmaceutical Group | pharmaceuticals | employment discrimination | 2019 | NY-NYCCHR | $35,000 |
| Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
| Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
| GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
| GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
| GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
| GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
| GLAXO SMITH KLINE | GlaxoSmithKline | pharmaceuticals | aviation safety violation | 2014 | FAA | $59,500 |
